vs

Side-by-side financial comparison of RYTHM, Inc. (RYM) and UNITED BANCORP INC (UBCP). Click either name above to swap in a different company.

RYTHM, Inc. is the larger business by last-quarter revenue ($10.7M vs $6.9M, roughly 1.5× UNITED BANCORP INC). UNITED BANCORP INC runs the higher net margin — 29.6% vs -127.6%, a 157.2% gap on every dollar of revenue. On growth, RYTHM, Inc. posted the faster year-over-year revenue change (242.0% vs 8.6%). Over the past eight quarters, RYTHM, Inc.'s revenue compounded faster (102.6% CAGR vs -0.7%).

RYTHM, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for rare genetic endocrine and metabolic disorders with high unmet medical needs. It primarily operates in the U.S. market, targeting pediatric and adult patient segments that lack standard effective treatment options.

United Bank was an American bank headquartered in Hartford, Connecticut, and had locations throughout Connecticut, Massachusetts and Rhode Island. The bank was acquired in 2019 by People's United Financial and branches were rebranded or closed.

RYM vs UBCP — Head-to-Head

Bigger by revenue
RYM
RYM
1.5× larger
RYM
$10.7M
$6.9M
UBCP
Growing faster (revenue YoY)
RYM
RYM
+233.4% gap
RYM
242.0%
8.6%
UBCP
Higher net margin
UBCP
UBCP
157.2% more per $
UBCP
29.6%
-127.6%
RYM
Faster 2-yr revenue CAGR
RYM
RYM
Annualised
RYM
102.6%
-0.7%
UBCP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RYM
RYM
UBCP
UBCP
Revenue
$10.7M
$6.9M
Net Profit
$-13.6M
$2.0M
Gross Margin
75.5%
Operating Margin
-121.5%
28.7%
Net Margin
-127.6%
29.6%
Revenue YoY
242.0%
8.6%
Net Profit YoY
44.1%
10.1%
EPS (diluted)
$-6.78
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RYM
RYM
UBCP
UBCP
Q4 25
$10.7M
$6.9M
Q3 25
$4.0M
$8.1M
Q2 25
$2.0M
$8.0M
Q1 25
$538.0K
$7.5M
Q4 24
$-7.5M
$6.3M
Q3 24
$1.9M
$7.4M
Q2 24
$3.0M
$7.4M
Q1 24
$2.6M
$7.0M
Net Profit
RYM
RYM
UBCP
UBCP
Q4 25
$-13.6M
$2.0M
Q3 25
$-10.7M
$1.9M
Q2 25
$-7.4M
$1.9M
Q1 25
$-1.6M
$1.9M
Q4 24
$-24.4M
$1.8M
Q3 24
$-18.7M
$1.8M
Q2 24
$-3.0M
$1.7M
Q1 24
$4.2M
$2.0M
Gross Margin
RYM
RYM
UBCP
UBCP
Q4 25
75.5%
Q3 25
34.0%
Q2 25
33.4%
Q1 25
16.7%
Q4 24
Q3 24
11.6%
Q2 24
37.6%
Q1 24
6.4%
Operating Margin
RYM
RYM
UBCP
UBCP
Q4 25
-121.5%
28.7%
Q3 25
-219.8%
23.7%
Q2 25
-332.9%
24.2%
Q1 25
-687.9%
24.5%
Q4 24
28.1%
Q3 24
-63.1%
23.9%
Q2 24
-28.5%
21.8%
Q1 24
13.6%
30.7%
Net Margin
RYM
RYM
UBCP
UBCP
Q4 25
-127.6%
29.6%
Q3 25
-263.8%
23.9%
Q2 25
-360.4%
24.0%
Q1 25
-302.2%
24.9%
Q4 24
324.4%
29.1%
Q3 24
-964.4%
24.7%
Q2 24
-99.3%
23.6%
Q1 24
163.0%
28.5%
EPS (diluted)
RYM
RYM
UBCP
UBCP
Q4 25
$-6.78
$0.35
Q3 25
$-5.33
$0.34
Q2 25
$-3.74
$0.33
Q1 25
$-0.83
$0.32
Q4 24
$-24.26
$0.31
Q3 24
$-17.28
$0.31
Q2 24
$-3.16
$0.30
Q1 24
$3.78
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RYM
RYM
UBCP
UBCP
Cash + ST InvestmentsLiquidity on hand
$32.2M
$46.5M
Total DebtLower is stronger
$80.6M
Stockholders' EquityBook value
$13.0M
$70.5M
Total Assets
$106.7M
$857.4M
Debt / EquityLower = less leverage
6.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RYM
RYM
UBCP
UBCP
Q4 25
$32.2M
$46.5M
Q3 25
$45.7M
Q2 25
$41.0M
$49.7M
Q1 25
$24.4M
$36.4M
Q4 24
$19.6M
Q3 24
$267.0K
$37.8M
Q2 24
$57.0K
$37.6M
Q1 24
$99.0K
$46.9M
Total Debt
RYM
RYM
UBCP
UBCP
Q4 25
$80.6M
Q3 25
$90.6M
Q2 25
$40.6M
Q1 25
$10.6M
Q4 24
Q3 24
$6.2M
Q2 24
$4.6M
Q1 24
Stockholders' Equity
RYM
RYM
UBCP
UBCP
Q4 25
$13.0M
$70.5M
Q3 25
$11.7M
$66.5M
Q2 25
$21.0M
$59.7M
Q1 25
$26.8M
$60.8M
Q4 24
$28.1M
$63.5M
Q3 24
$5.5M
$65.5M
Q2 24
$8.5M
$60.6M
Q1 24
$-5.5M
$63.2M
Total Assets
RYM
RYM
UBCP
UBCP
Q4 25
$106.7M
$857.4M
Q3 25
$115.2M
$866.8M
Q2 25
$69.5M
$847.9M
Q1 25
$45.6M
$830.7M
Q4 24
$54.0M
$816.7M
Q3 24
$39.0M
$825.5M
Q2 24
$39.4M
$821.8M
Q1 24
$40.6M
$834.0M
Debt / Equity
RYM
RYM
UBCP
UBCP
Q4 25
6.19×
Q3 25
7.73×
Q2 25
1.94×
Q1 25
0.40×
Q4 24
Q3 24
1.13×
Q2 24
0.54×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RYM
RYM
UBCP
UBCP
Operating Cash FlowLast quarter
$-3.0M
$10.5M
Free Cash FlowOCF − Capex
$-1.3M
FCF MarginFCF / Revenue
-19.2%
Capex IntensityCapex / Revenue
171.0%
Cash ConversionOCF / Net Profit
5.14×
TTM Free Cash FlowTrailing 4 quarters
$-819.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RYM
RYM
UBCP
UBCP
Q4 25
$-3.0M
$10.5M
Q3 25
$-5.4M
$3.2M
Q2 25
$-8.4M
$3.8M
Q1 25
$-6.7M
$1.1M
Q4 24
$-5.3M
$8.4M
Q3 24
$-1.4M
$4.4M
Q2 24
$-1.8M
$-789.0K
Q1 24
$-3.0M
$3.6M
Free Cash Flow
RYM
RYM
UBCP
UBCP
Q4 25
$-1.3M
Q3 25
$-367.0K
Q2 25
$1.5M
Q1 25
$-594.0K
Q4 24
$-1.2M
Q3 24
$-1.7M
Q2 24
$-1.8M
$-1.5M
Q1 24
$-3.0M
$223.0K
FCF Margin
RYM
RYM
UBCP
UBCP
Q4 25
-19.2%
Q3 25
-4.5%
Q2 25
18.3%
Q1 25
-7.9%
Q4 24
-19.7%
Q3 24
-22.9%
Q2 24
-61.2%
-20.5%
Q1 24
-115.1%
3.2%
Capex Intensity
RYM
RYM
UBCP
UBCP
Q4 25
171.0%
Q3 25
43.7%
Q2 25
29.0%
Q1 25
22.0%
Q4 24
152.8%
Q3 24
82.8%
Q2 24
0.1%
9.8%
Q1 24
0.1%
48.6%
Cash Conversion
RYM
RYM
UBCP
UBCP
Q4 25
5.14×
Q3 25
1.64×
Q2 25
1.98×
Q1 25
0.57×
Q4 24
4.57×
Q3 24
2.42×
Q2 24
-0.45×
Q1 24
-0.71×
1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RYM
RYM

Nonlicensing Revenue$9.5M89%
Cultivation Business Discontinued Operations$1.2M11%

UBCP
UBCP

Segment breakdown not available.

Related Comparisons